The development of


Journal

Nuclear medicine and biology
ISSN: 1872-9614
Titre abrégé: Nucl Med Biol
Pays: United States
ID NLM: 9304420

Informations de publication

Date de publication:
01 2021
Historique:
received: 01 02 2020
accepted: 16 02 2020
pubmed: 10 3 2020
medline: 5 10 2021
entrez: 10 3 2020
Statut: ppublish

Résumé

The prospects for using carbon-11 labelled compounds in molecular imaging has improved with the development of diverse synthesis methods, including

Identifiants

pubmed: 32147168
pii: S0969-8051(20)30038-X
doi: 10.1016/j.nucmedbio.2020.02.005
pii:
doi:

Substances chimiques

Carbon Radioisotopes 0
Carbon-11 0
Radiopharmaceuticals 0
Carbon Monoxide 7U1EE4V452

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-137

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Jonas Eriksson (J)

Department of Medicinal Chemistry, Division of Organic Pharmaceutical Chemistry, Uppsala University, Uppsala, Sweden. Electronic address: jonas.eriksson@ilk.uu.se.

Gunnar Antoni (G)

Department of Medicinal Chemistry, Division of Organic Pharmaceutical Chemistry, Uppsala University, Uppsala, Sweden.

Bengt Långström (B)

Department of Chemistry, Uppsala University, Uppsala, Sweden.

Oleksiy Itsenko (O)

Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH